Breaking News

Financial Report: ICON

By Kristin Brooks | February 20, 2014

Revenues up 15% in the quarter

4Q Revenues: $345 million (+15%)

4Q Earnings: $33.5 million (+62%)

FY Revenues: $1.34 billion (+20%)

FY Earnings: $102.8 million (+86%)

Comments: Operating income was $38.7 million or 11% of revenue in the quarter, and net business awards were $446 million representing a book to bill of 1.29. For the year operating income before non-recurring charges was $130.2 million or 10% of revenue, and net new business awards were $1.6 billion, representing a book to bill of 1.23. Backlog increased 12% for the year to $3.1 billion.
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments